---
layout: minimal-medicine
title: Asparaginase (E. coli)
---

# Asparaginase (E. coli)
### Generic Name
Asparaginase (E. coli)

### Usage
Asparaginase (E. coli) is primarily used in the remission induction phase of acute lymphoblastic leukemia (ALL).  It's always administered in combination with other chemotherapy drugs, not as a standalone treatment.  While its main application is in ALL, off-label uses exist for treating lymphoblastic lymphoma, but these are less common and require careful consideration by a healthcare professional.

### Dosage

Dosage of Asparaginase (E. coli) varies significantly depending on the specific treatment protocol, the patient's age, weight, and the phase of treatment (induction, intensification, maintenance).  There is no single standard dose.  The following represent examples and *should not* be interpreted as universally applicable:

**Adults:** Doses range from 200-1000 units/kg/day for 28 days (daily administration) or 400-600 units/kg on a weekly schedule (intermittent).  Off-label regimens (Hyper-CVAD, Linker, CALGB-8811) utilize different dosage schedules and routes of administration.  These regimens specify doses in units/m² or units/week, with variations depending on the specific treatment phase.  Always consult detailed protocols for precise dosage guidance in such cases.

**Children:** Pediatric dosing is also highly protocol-dependent and expressed in units/m². Examples include 6000 units/m²/dose several times weekly (CCG 1922) or 25000 units/m² for one dose or weekly for several weeks (DFCI-ALL Consortium protocols).  Dosage for adolescents may align with adult protocols.

**Routes of Administration:** Asparaginase (E. coli) can be administered intravenously (IV), intramuscularly (IM), and subcutaneously (SC; off-label).  The choice of route depends heavily on the treatment protocol.  IV administration usually requires infusion over at least 30 minutes.  IM injections should be deep into a large muscle, limiting single injection volume to 2 mL to avoid local reactions.

**Dosage Adjustments:**  Dosage adjustments are necessary based on several factors, including organ function and the occurrence of side effects.  Hepatotoxicity (liver damage) is a particular concern, requiring careful monitoring of liver function tests (LFTs) and potential dose reductions or discontinuation.  Similar considerations apply to pancreatitis, neurotoxicity, hyperammonemia, hyperglycemia, and thrombotic events.  Renal impairment may also necessitate adjustments, though specific guidelines may not be available.  Always refer to the detailed prescribing information for accurate adjustments based on laboratory values and observed adverse reactions.


### Side Effects

Common side effects include:

* Nausea
* Vomiting
* Injection site reactions
* Fever

Less common, but potentially serious side effects:

* Allergic reactions (ranging from mild rash to anaphylaxis)
* Pancreatitis (inflammation of the pancreas)
* Hepatotoxicity (liver damage)
* Neurotoxicity (affecting the nervous system, potentially leading to seizures or encephalopathy)
* Thrombotic events (blood clots)
* Hyperglycemia (high blood sugar)
* Hyperammonemia (high levels of ammonia in the blood)

**If any adverse effects occur, especially serious ones, consult a healthcare provider immediately.**

### How it Works

Asparaginase (E. coli) is an enzyme that breaks down the amino acid L-asparagine.  Leukemic cells, particularly lymphoblasts, are often deficient in their ability to produce this amino acid, making them dependent on external sources. By depleting L-asparagine, asparaginase inhibits protein synthesis in these cells, leading to their death (apoptosis).  Normal cells, however, are generally capable of producing their own L-asparagine, so they are less affected.  This is a cycle-specific effect, primarily targeting cells in the G1 phase of the cell cycle.

### Precautions

* **Hypersensitivity:**  Asparaginase (E. coli) can cause severe allergic reactions, including anaphylaxis.  Patients with a history of hypersensitivity to other forms of asparaginase are at increased risk.
* **Hepatotoxicity:**  Monitor liver function tests closely.
* **Pancreatitis:**  This is a potentially life-threatening side effect requiring prompt medical attention.
* **Neurotoxicity:**  Observe for signs of neurological problems.
* **Thrombosis:**  Increased risk of blood clots.
* **Pregnancy and Breastfeeding:**  Use during pregnancy is generally avoided due to potential harm to the fetus.  The safety of use during breastfeeding is unknown.
* **Drug Interactions:**  Interaction with other drugs (e.g., methotrexate, vincristine) may occur.  Inform your doctor of all medications you are taking.
* **Other Precautions:**  Asparaginase (E. coli) should only be administered by or under the close supervision of healthcare professionals experienced in cancer chemotherapy.  Full resuscitative facilities should be readily available.


### FAQs

* **How is Asparaginase (E. coli) stored?**  Follow the specific storage instructions provided by your pharmacist or on the medication label. Generally, it needs refrigeration.
* **What if I miss a dose?**  Do not try to make up for missed doses without consulting your doctor. The dosing schedule is crucial to the effectiveness of the treatment and should not be altered.
* **How long does treatment last?**  Treatment duration varies depending on the individual's response to therapy and is determined by the oncologist.
* **Are there other types of asparaginase?** Yes, there are other forms of asparaginase from different bacterial sources (e.g., Erwinia), as well as pegylated versions (e.g., pegaspargase, calaspargase pegol). These may have different properties and side-effect profiles.  They are not interchangeable without specific medical direction.
* **Can I drive or operate machinery while taking this medicine?**  You should discuss this with your doctor, especially given potential side effects such as neurotoxicity, fatigue, or nausea.


**Disclaimer:** This information is for general knowledge and does not constitute medical advice.  Always consult a healthcare professional for diagnosis, treatment, and any questions regarding your health or medication.  The information provided here is not exhaustive and may not cover all aspects of Asparaginase (E. coli) usage.  Always refer to the official prescribing information for complete details.
